Nanomedicine News

RSS
Tekmira Reports More Positive Preclinical Data from TKM-Ebola and TKM-Marburg Programs

Tekmira Reports More Positive Preclinical Data from TKM-Ebola and TKM-Marburg Programs

EMA Awards Orphan Drug Designation to NanoViricides’s DengueCide

EMA Awards Orphan Drug Designation to NanoViricides’s DengueCide

AAPS Honors Nanoresearchers as 2013 Fellows

AAPS Honors Nanoresearchers as 2013 Fellows

Student Nanomedicine Researchers Named National Finalists in Siemens Math, Science & Technology Competition

Student Nanomedicine Researchers Named National Finalists in Siemens Math, Science & Technology Competition

Alnylam Reports Positive Results from Tekmira LNP Technology-Enabled Patisiran Clinical Trial

Alnylam Reports Positive Results from Tekmira LNP Technology-Enabled Patisiran Clinical Trial

Panacea Presents Papers on Nanoparticle-Based Therapeutic Cancer Vaccine at SITC Annual Meeting

Panacea Presents Papers on Nanoparticle-Based Therapeutic Cancer Vaccine at SITC Annual Meeting

Leading Research Institutes and Charitable Foundations Contract with imec for Neuroscience Research

Leading Research Institutes and Charitable Foundations Contract with imec for Neuroscience Research

Researchers Report Nanoparticles Filled with Chemotherapeutic Drugs Can Destroy Breast Cancer

Researchers Report Nanoparticles Filled with Chemotherapeutic Drugs Can Destroy Breast Cancer

Engineering Tetrapod Quantum Dots to Improve Diagnostic Accuracy of Biomedical Assays and Devices for Quantum Materials Corp.

UltraSM® Membranes for Chip-Sized Diagnostics from SiMPore

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.